Lingke
X

 

      +86 0571-87711179

ychen1@lynkpharma.com


lynk Pharmaceutical (Hangzhou) Co., Ltd.    |    浙ICP备18056091号-1   |   Powered by www.300.cn    |   Manager

CONTACT US

website

Search

291 Fucheng Road, Bldg 5-402, Jianggan, Hangzhou,
Zhejiang 310018, China

>
Leadership

DR. ZHAO-KUI (ZK) WAN

Chairman of Board; Founder & CEO
◇  Boston Univ. (Ph.D.), Harvard Univ. (postdoc)
◇  18 years @ Wyeth/Pfizer, JNJ (Head of Chemistry)
◇  >40 Journal publications; >140 global & regional patents.
◇  HSD-016, HSD-621 & PF-06700841 (Phase II) & HalavenTM
◇  Co-founder, Chinese BioMedical Association (CABA)
◇  Fellow of the Royal Society of Chemistry, RSC, UK
◇  Young Industrial Investigators Award, American Chemical Society
◇  Steering Committee Member, CICR, AACR
Close

DR. JUN WANG

Co-founder & CSO
◇  Kobe Unive. (Ph.D.); UT S.W. Medical Center (postdoc)
◇  >25 years @ Merck, Medicilon
◇  Publications in Nature, PNAS, JBC; >40 US global & regional patents.
◇  Invanz®, KU-2285, AK-2123, Platensimycin & Platencin
◇  Outstanding reviewer for Biochem. Pharmacol. 2015
◇  Leadership Award, Merck, 2003
◇  Distinguished Director, Cancer Institute of CAMS 1989
◇  Editorial Board Members for 3 English Journals
Close

DR. MICHAEL VAZQUEZ

Co-founder, SVP & Head of Chemistry
◇  Northwestern Univ. (Ph.D.); RTI (Postdoc)
◇  >30 years @ Pharmacia/Pfizer (Director & Associate Research Fellow)
◇  >20 Journal publications; >470 global & regional patents.
◇  Agenerase®, Lexiva®, Prezista® & Xalkori®
    PF-04965842 (Phase III), PF-06763809 (Phase Ib)
◇  Distinguished Alumni (2016), Northern Illinois University;
◇ Frequently invited speakers at conferences & universities
Close

MR. JAROD CHEN

Co-founder & COO
◇ China Medical University (Ph.D. candidate)
   Seoul University (Visiting Scholar)
◇  >11 years @ Changjiang Capital, Sinopharm, Conba.
◇  Broad experience in investment and operation
◇  Participated in biotech investment & post investment management
◇  Certified mutual fund manager.
◇  Member of Pharmaceutical Management Committee, Zhejiang
   Pharmaceutical Association
Close

Team members contributed to the research and development of clinical and
marketed drugs